NCT00649129View on ClinicalTrials.gov

Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Healthy
Interventions
DRUG

Oxybutynin Chloride ER Tablets 10 mg

2x10mg, single dose fasting

DRUG

Ditropan XL® Tablets 10 mg

2x10mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY